Our webinar on PBPK Modeling features speakers Dr. Steven Webb and Dr. David Cowie from Syngenta. Together, they will share models to assess how Tyrosine aminotransferase (TAT) catalyzes the conversion of tyrosine to accumulation of hydroxyphenylpyruvic acid (HPPA) and how its activity varies among mammalian species. Species differences also exist in the ability to utilize alternative pathways for tyrosine catabolism …
Our first September 2024 webinar focuses on novel methods to assess relevant risk in humans with Les Recio, PhD, DABT, ATS, and Rasim Barutcu, PhD. We believe these approaches are a positive and proven way forward for expediting research and reducing the use of animals. While we do not offer a training course for integrating these tools, we do offer …
If you attended /watched the recordings from the last two webinars, you might remember that Dr. Paul White and Dr. George Johnson highlighted the need to develop a conceptual framework to use genotoxicity data quantitatively for risk assessment. In this webinar, Marc Beal, PhD, a Research Scientist and Head of the Molecular and Applied Toxicology Section within the Food and …
In continuing the momentum on the topic of quantitative interpretation of genotoxicity dose-response data for risk assessment, we have the pleasure of hosting Paul A. White, PhD as our next webinar speaker. Dr White is a research scientist at the Environmental Health Science and Research Bureau of Health Canada in Ottawa, Ontario, Canada. What you will learn: Assumptions underlying the …
Elevating NAMs in genotoxicity to reduce reliance on animal testing is a focus of our research efforts at ScitoVation. In addition to launching a 21st Century Genotoxicity program, we want to ensure you receive highly relevant information on the latest development in genotoxicity research. As such, we are pleased to host George Johnson PhD, from Swansea University. Dr Johnson is …
Dr Alexandra Noël speaks about using in vitro assays to assess the electronic nicotine delivery system aerosols. What you’ll learn: Overview of EVALI outbreak and harm caused. Known effects of e-cigarettes. How Air-liquid interface (ALI) physiologically relevant in vitro models can be used to assess the pulmonary effects associated with exposure to inhaled e-cig aerosols containing nicotine. Watch the Recording …
It was an honor to have Professor Shareen Doak with us to discuss her groundbreaking research. Her research on New Approach Methodologies (NAMs) and overcoming limitations of OECD Test Guidelines for nanomaterials (NMs) testing is leading edge brought up a lot of great questions. The link to the recording is below. What you’ll learn: The need to adapt existing …
We are excited to present our first recorded installment for our 2024 webinar series. Jeff Fisher, PhD, ScitoVation’s Senior Science Fellow, will be speaking about thyroid disruption and IVIVE based on his latest publication. ScitoVation scientists continue advancing the benefits of IVIVE modeling. What you’ll learn: Thyroid modeling demonstrating IVIVE for a molecular initiating event determined in vitro How to …
Our speaker is Dustin Kapraun, PhD, physical scientist with the Center for Public Health and Environmental Assessment (CPHEA) in the Office of Research and Development (ORD) at the U.S. Environmental Protection Agency (EPA). In developing human health risk assessments, it is important to consider pregnant women, developing fetuses, and nursing children because chemical exposures experienced by these groups can lead …